Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hohlfeld

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Agents and Actions. Supplements|January 1, 1992
Oral cicaprost reduces platelet and neutrophil activation in experimental hypercholesterolemiaT Hohlfeld, A Weber, K Schrör
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injuryT Hohlfeld, H Strobach, K Schrör
Thrombosis Research|December 15, 1991
ADP-induced second wave aggregation in platelet rich plasma from hypercholesterolemic rabbitsA Weber, T Hohlfeld, K Schrör
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 11, 2006
Aspirin resistance - does it clinically matter?Karsten Schrör, T Hohlfeld, A-A Weber
Platelets|June 28, 2006
cAMP is an important messenger for ADP-induced platelet aggregationA A Weber, T Hohlfeld, K Schrör
Thrombosis and Haemostasis|January 1, 1994
Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemiaT Hohlfeld, F Scharnowski, M Braun, et al.
Journal of Cardiovascular Pharmacology|June 1, 1994
Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonistT Hohlfeld, M Braun, H Strobach, et al.
The International Journal of Oral & Maxillofacial Implants|May 5, 2000
Improvement of epidermal adhesion by surface modification of craniofacial abutmentsM Klein, T Hohlfeld, P Moormann, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia. A double-blind, placebo-controlled, prospective studyD Kaczmarek, T Hohlfeld, G Wambach, et al.
Agents and Actions. Supplements|January 1, 1992
Oral cicaprost protects from hypercholesterolaemia-induced impairment of coronary vasodilationI Woditsch, T Hohlfeld, H Strobach, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Agents and Actions. Supplements|January 1, 1992
Oral cicaprost reduces platelet and neutrophil activation in experimental hypercholesterolemiaT Hohlfeld, A Weber, K Schrör
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1993
Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injuryT Hohlfeld, H Strobach, K Schrör
Thrombosis Research|December 15, 1991
ADP-induced second wave aggregation in platelet rich plasma from hypercholesterolemic rabbitsA Weber, T Hohlfeld, K Schrör
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 11, 2006
Aspirin resistance - does it clinically matter?Karsten Schrör, T Hohlfeld, A-A Weber
Platelets|June 28, 2006
cAMP is an important messenger for ADP-induced platelet aggregationA A Weber, T Hohlfeld, K Schrör
Thrombosis and Haemostasis|January 1, 1994
Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemiaT Hohlfeld, F Scharnowski, M Braun, et al.
Journal of Cardiovascular Pharmacology|June 1, 1994
Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonistT Hohlfeld, M Braun, H Strobach, et al.
The International Journal of Oral & Maxillofacial Implants|May 5, 2000
Improvement of epidermal adhesion by surface modification of craniofacial abutmentsM Klein, T Hohlfeld, P Moormann, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia. A double-blind, placebo-controlled, prospective studyD Kaczmarek, T Hohlfeld, G Wambach, et al.
Agents and Actions. Supplements|January 1, 1992
Oral cicaprost protects from hypercholesterolaemia-induced impairment of coronary vasodilationI Woditsch, T Hohlfeld, H Strobach, et al.
Pageof 6